Comparison of Cardiac Power Output and Exercise Performance in Patients With Left Ventricular Assist Devices, Explanted (Recovered) Patients, and Those With Moderate to Severe Heart Failure

American Journal of Cardiology

Volumn 105, Issue 12, 2010, Pages 1780-1785

  Jakovljevic, Djordje G ^a,b   George, Robert S ^c,d   Donovan, Gay ^b   Nunan, David ^b   Henderson, Keiran ^b   Bougard, Robert S ^c   Yacoub, Magdi H ^d   Birks, Emma J ^c,d   Brodie, David A ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b BUCKINGHAMSHIRE NEW UNIVERSITY   (United Kingdom)

^c ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^d Heart Science Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN II ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLENBUTEROL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT;

ADULT; ANAEROBIC THRESHOLD; ARTICLE; ASSISTIVE TECHNOLOGY DEVICE; CARDIAC POWER OUTPUT; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; EXERCISE; EXPLANT; HEART FAILURE; HEART MUSCLE; HEART OUTPUT; HUMAN; IMPLANT; LEFT VENTRICULAR ASSIST DEVICE; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

ADULT; ELECTROCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; YOUNG ADULT;

EID: 77953120950     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.362     Document Type: Article

References (30)

1. Cotter G., Williams S.G., Vered Z., and Tan L.B. Role of cardiac power in heart failure. Curr Opin Cardiol 18 (2003) 215-222
2. Tan L.B. Cardiac pumping capability and prognosis in heart failure. Lancet 13 (1986) 1360-1363
3. Fincke R., Hochman J.S., Lowe A.M., Menon V., Slater J.N., Web J.G., LeJemtel T.H., and Cotter G. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the shock trial registry. J Am Coll Cardiol 44 (2004) 340-348
4. Mendoza D.D., Cooper H.A., and Panza J.A. Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J 153 (2007) 366-370
5. Roul G., Moulichon M.E., Bareiss P., Gries P., Koegler A., Sacrez J., Germain P., Mossard J.M., and Sacrez A. Prognostic factors of chronic heart failure in NYHA class II or III: value of invasive exercise haemodynamic data. Eur Heart J 16 (1995) 1387-1398
6. Tan L.B., and Littler W.A. Measurement of cardiac reserve in cardiogenic shock: implication for prognosis and management. Br Heart J 64 (1990) 121-128
7. Williams S.G., Cooke G.A., Wright D.J., Parsons W.J., Riley R.L., Marshall P., and Tan L.B. Peak exercise cardiac power output: a indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 22 (2001) 1496-1503
8. Tan L.B. Evaluation of cardiac dysfunction, cardiac reserve and inotropic response. Postgrad Med J 67 (1991) S10-S20
9. Birks E.J., Tansley P.D., Hardy J., George R.S., Bowles C.T., Burke M., Banner N.R., Khaghani A., and Yacoub M.H. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355 (2006) 1873-1884
10. Jakovljevic D.G., Nunan D., Donovan G., Hodges L.D., Sandercock G.R., and Brodie D.A. Comparison of cardiac output determined by different rebreathing methods at rest and at peak exercise. Eur J Appl Physiol 102 (2008) 593-599
11. Agostoni P., Cattadori G., Apostolo A., Contini M., Palermo P., Marenzi G., and Wasserman K. Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation. J Am Coll Cardiol 46 (2005) 1779-1781
12. Borg G.A. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14 (1982) 377-381
13. Beaver W.L., Wasserman K., and Whipp B.J. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 60 (1986) 2020-2027
14. Cooke G.A., Marshall P., Al-Timman J.K., Riley R., Hainsworth R., and Tan L.B. Physiological cardiac reserve: development of a non-invasive method and first estimates in man. Heart 79 (1998) 289-294
15. Meaney E., Alva F., Moguel R., Meaney A., Alva J., and Webel R. Formula and nomogram for the sphygmomanometric calculation of the mean arterial pressure. Heart 84 (2000) 64
16. Chua T.P., Ponikowski P., Harrington D., Anker S.D., Webb-Peploe K., Clarks A.L., Poole-Wilson P.A., and Coats A.J.S. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 29 (1997) 1585-1590
17. Wasserman K., Hansen J.E., Sue D.Y., Casaburi R., and Whipp B.J. Principles of Exercise Testing and Interpretation (1999), Lippincott Williams & Wilkins, Baltimore, Maryland
18. Williams S.G., Barker D., Goldspink D.F., and Tan L.B. A reappraisal of concepts in heart failure: central role of cardiac reserve. Arch Med Sci 1 (2005) 65-74
19. Bromley P.D., Hodges L.D., and Brodie D.A. Physiological range of peak cardiac power output in healthy adults. Clin Physiol Funct Imaging 26 (2006) 240-246
20. Maybaum S., Mancini D., Xydas S., Starling R.C., Aaronson K., Pagani F.D., Miller L.W., Margulies K., McRee S., Frazier O.H., Torre-Amione G., and LVAD Working Group. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation 115 (2007) 2497-2505
21. Terracciano C.M., Harding S.E., Adamson D., Koban M., Tansley P., Birks E.J., Barton P.J., and Yacoub M.H. Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. Eur Heart J 24 (2003) 1329-1339
22. Takeishi Y., Jalili T., Hoit B.D., Kirkpatrick D.L., Wagoner L.E., Abraham W.T., and Walsh R.A. Alterations in calcium-cycling proteins and g-alpha-q signalling after left ventricular assist device support in failing human hearts. Cardiovasc Res 45 (2000) 883-888
23. Liden H., Karason K., Bergh C.H., Nilsson F., Koul B., and Wiklund L. The feasibility of left ventricular mechanical support as a bridge to cardiac recovery. Eur J Heart Fail 9 (2007) 525-530
24. Miller L.W., Pagani F.D., Russell S.D., John R., Boyle A.J., Aaronson K.D., Conte J.V., Naka Y., Mancini D., Delgado R.M., MacGillivray T.E., Farrar D.J., Frazier O.H., and HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357 (2007) 885-896
25. Dandel M., Weng Y., Siniawski H., Potapov E., Lehmkuhl H.B., and Hetzer R. Long term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 112 suppl (2005) I-37-I-I-3745
26. Mancini D.M., Beniaminovitz A., Levin H., Catanese K., Flannery M., DiTullio M., Savin S., Cordisco M.E., Rose E., and Oz M. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98 (1998) 2383-2389
27. Yacoub M.H. A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 22 (2001) 534-540
28. Mancini D., Goldsmith R., Levin H., Beniaminovitz A., Rose E., Catanese K., Flannery M., and Oz M. Comparison of exercise performance in patients with chronic severe heart failure versus left ventricular assist devices. Circulation 98 (1998) 1178-1183
29. Haft J., Armstrong W., Dyke D.B., Aaronson K.D., Koelling T.M., Farrar D.J., and Pagani F.D. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation 116 Suppl I (2007) I-8-I-I-815
30. Richard R., Verdier J.C., Duvallet A., Rosier S.P., Leger P., Nignan A., and Rieu M. Chronotropic competence in endurance trained heart transplant recipients: heart rate is not a limiting factor for exercise capacity. J Am Coll Cardiol 33 (1999) 192-197